Publication | Closed Access

Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation

SclerostinBone Morphogenic ProteinCell SignalingPhysiologyOsteoarthritisMap Kinase ActivationCytoskeletonRankl-induced Osteoclast DifferentiationOsteoporosisMedicineCell BiologyCellular PhysiologyExtracellular MatrixActin Ring Formation